Plain-English translation of NCT07342920 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Cystic Fibrosis research guide →Researchers want to understand how many adults with cystic fibrosis smoke or vape, and how often. Many people assume that patients with cystic fibrosis don't smoke, but there's actually very little information about this in France. This study will help doctors learn about the real situation so they can provide better support and prevention advice.
Cystic fibrosis patients are living longer and healthier lives thanks to new treatments, which means more of them may face choices about smoking or vaping. Doctors need to understand how common these habits are so they can help patients make healthy decisions and ensure these habits don't interfere with their treatment.
You likely qualify if…
You likely don't qualify if…
You would visit the Strasbourg Adult Cystic Fibrosis Center and share information about your smoking and vaping habits through a survey or conversation with the research team. This is not a treatment study—you won't be taking any new medication or undergoing procedures. It's simply a way to help doctors understand the current situation so they can better support their patients.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France
Enrollment target
~100 participants
Started
October 2025
Primary completion
October 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Romain Kessler, MD, PhD
University Hospital, Strasbourg, France
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.